'No More Questions' On Scrutiny In EU Medical Device Reform Talks
This article was originally published in SRA
Executive Summary
While it is premature to speak of agreement, it seems that the three parties involved in negotiating the future EU Medical Device Regulation might be closer to reaching a decision on one of the biggest sticking points with the proposed legislation - the scrutiny of high-risk medical devices.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.